Helmstdter J, Frenis K, Filippou K, Grill A, Dib M, Kalinovic S, et al
There is a lack of providers who have adequate training to understand and treat their unique health risks. Wellstar believes every person should have access to safe, high-quality healthcare
PlexusDx offers the Precision Peptide Genetic Testa peptide-pathway analysis examining 14 metabolic pathways and 49 peptidesto identify how you may respond to GLP-1 therapy
*In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
Want an extra boost
It is approved for type 2 diabetes and chronic weight management in adults with obesity or overweight with weight-related comorbidities, conditions often associated with insulin resistance